Bioxyne Ltd (BXN)

Sydney
Currency in AUD
0.029
+0.001(+3.57%)
Delayed Data
BXN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week High
Fair Value
Day's Range
0.0280.029
52 wk Range
0.0040.029
Key Statistics
Edit
Bid/Ask
0.028 / 0.029
Prev. Close
0.028
Open
0.029
Day's Range
0.028-0.029
52 wk Range
0.004-0.029
Volume
336.28K
Average Volume (3m)
2.05M
1-Year Change
125%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BXN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Bioxyne Ltd Company Profile

Bioxyne Limited, a life sciences and consumer health products company, engages in the manufacture and distribution of consumer health products, patented probiotics, health supplements, therapeutic goods, and alternative medicines. The company manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabinoids, cannabis extracts, cannabis pastilles, THC flowers, vapes, oral liquids, nootropic and skin care products, and mushroom complexes. It also develops various functional food products, such as lactobacillus fermentum VRI-003 for over-the counter gut health immune supplement products. In addition, the company provides product research and development services, and telemedicine services. Further, it operates BLS Clinics, a telehealth platform; and CanXChange Australia, a machine-learning driven B2B technology platform for sponsors, manufacturers, cultivators, and pharmacies to interact, manage chain of custody, and buy and sell bulk starting materials, APIs, and finished products in a regulated environment. The company offers its products under the Dr Watson, Mirai Solution, and Apothecary CBD brands. It provides its products online, as well as through wholesale and direct sales in Australia, the United States, the United Kingdom, Japan, Czechia, Switzerland, France, and Germany. The company was incorporated in 1998 and is headquartered in Sydney, Australia.

Compare BXN to Peers and Sector

Metrics to compare
BXN
Peers
Sector
Relationship
P/E Ratio
−4.5x−2.3x11.6x
PEG Ratio
0.01−0.010.03
Price/Book
15.9x1.4x1.5x
Price / LTM Sales
6.0x1.4x0.9x
Upside (Analyst Target)
-91.9%24.9%
Fair Value Upside
Unlock−3.5%11.3%Unlock

Earnings

Latest Release
Feb 23, 2023
EPS / Forecast
-- / --
Revenue / Forecast
1.21M / --
EPS Revisions
Last 90 days

FAQ

What Is the Bioxyne Ltd (BXN) Stock Price Today?

The Bioxyne Ltd stock price today is 0.029

What Stock Exchange Does Bioxyne Ltd Trade On?

Bioxyne Ltd is listed and trades on the Sydney stock exchange.

What Is the Stock Symbol for Bioxyne Ltd?

The stock symbol for Bioxyne Ltd is "BXN."

What Is the Bioxyne Ltd Market Cap?

As of today, Bioxyne Ltd market cap is 59.43M.

What is Bioxyne Ltd Earnings Per Share?

The Bioxyne Ltd EPS is -0.007.

From a Technical Analysis Perspective, Is BXN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.